ICIs Exceptional Long Response in TNBC: Addressing the Issue of Optimal ICIs Duration. Two Cases and Review of the Literature

ABSTRACT Background Breast cancer is the leading cause of cancer‐related mortality in women, with triple‐negative breast cancer (TNBC) being an aggressive subtype associated with poor prognosis and limited treatment options. TNBC is known for its immunogenic characteristics, including high genetic i...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Simone Rota, Carolina Sciortino, Silvia Damian, Matteo Duca, Giorgia Villa, Matteo De Monte, Elisabella Ebrahem, Laura Cattaneo, Chiara Volpi, Alessandra Casale, Diletta Sorrentino, Sara Pessina, Antonia Martinetti, Filippo De Braud, Sara Cresta
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Wiley 2025-11-01
Saila:	Cancer Reports
Gaiak:	breast cancer immune checkpoint inhibitors immunotherapy systemic anticancer treatment triple negative breast cancer
Sarrera elektronikoa:	https://doi.org/10.1002/cnr2.70397
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!